These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15070695)

  • 21. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
    Wang X; Zhang Z; Yao C
    Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.
    Van Valckenborgh E; Croucher PI; De Raeve H; Carron C; De Leenheer E; Blacher S; Devy L; Noël A; De Bruyne E; Asosingh K; Van Riet I; Van Camp B; Vanderkerken K
    Am J Pathol; 2004 Sep; 165(3):869-78. PubMed ID: 15331411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thalidomide on the expression of angiogenesis growth factors in human A549 lung adenocarcinoma cells.
    Li X; Liu X; Wang J; Wang Z; Jiang W; Reed E; Zhang Y; Liu Y; Li QQ
    Int J Mol Med; 2003 Jun; 11(6):785-90. PubMed ID: 12736723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
    García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
    Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.
    Lamorte S; Ferrero S; Aschero S; Monitillo L; Bussolati B; Omedè P; Ladetto M; Camussi G
    Leukemia; 2012 May; 26(5):1081-90. PubMed ID: 22024722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy.
    Bataille R; Robillard N; Pellat-Deceunynck C; Amiot M
    Immunol Rev; 2003 Aug; 194():105-11. PubMed ID: 12846811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
    Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of VEGF and its receptors by myeloma cells.
    Kumar S; Witzig TE; Timm M; Haug J; Wellik L; Fonseca R; Greipp PR; Rajkumar SV
    Leukemia; 2003 Oct; 17(10):2025-31. PubMed ID: 14513053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimyeloma effects of resveratrol through inhibition of angiogenesis.
    Hu Y; Sun CY; Huang J; Hong L; Zhang L; Chu ZB
    Chin Med J (Engl); 2007 Oct; 120(19):1672-7. PubMed ID: 17935668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.
    Bellamy WT
    Semin Oncol; 2001 Dec; 28(6):551-9. PubMed ID: 11740808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma.
    Khan R; Sharma M; Kumar L; Husain SA; Sharma A
    Ann Hematol; 2013 Jan; 92(1):101-9. PubMed ID: 22971811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
    Vacca A; Scavelli C; Montefusco V; Di Pietro G; Neri A; Mattioli M; Bicciato S; Nico B; Ribatti D; Dammacco F; Corradini P
    J Clin Oncol; 2005 Aug; 23(23):5334-46. PubMed ID: 15939924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.
    Bolkun L; Lemancewicz D; Sobolewski K; Mantur M; Semeniuk J; Kulczynska A; Kloczko J; Dzieciol J
    Adv Med Sci; 2013; 58(1):118-25. PubMed ID: 23333895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor receptors VEGFR1 in cultured multiple myeloma cells: correlation with immunophenotype and drug resistance.
    Kalitin NN; Kostyukova MN; Kakpakova ES; Tupitsyn NN; Karamysheva AF
    Bull Exp Biol Med; 2012 Oct; 153(6):882-5. PubMed ID: 23113309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.
    Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM
    Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.